Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:06 pm Purchase | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 3,355,917 6.2% | 603,495 (+21.93%) | View |
| 2023-02-14 08:53 am Sale | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 0 0% | -3,216,997 (Position Closed) | View |
| 2022-09-29 4:30 pm Purchase | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 2,752,422 5.1% | 2,752,422 (New Position) | View |
| 2022-08-15 11:29 am Sale | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 3,756,915 6.9% | -1,264,523 (-25.18%) | View |
| 2022-07-08 4:56 pm Sale | 13G | Passage Bio, Inc. PASG | BlackRock Inc. BLK | 1,368,347 2.5% | -2,123,208 (-60.81%) | View |
| 2022-05-05 4:56 pm Purchase | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 6,841,423 12.6% | 894,100 (+15.03%) | View |
| 2022-02-14 08:59 am Purchase | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 3,216,997 5.95% | 364,057 (+12.76%) | View |
| 2022-02-14 07:01 am Unchanged | 13G | Passage Bio, Inc. PASG | Access Industries Holdings LLC | 2,616,630 4.8% | 0 (Unchanged) | View |
| 2022-02-09 12:22 pm Sale | 13G | Passage Bio, Inc. PASG | LAV Prescience Ltd | 2,199,676 4.1% | -627,652 (-22.20%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Passage Bio, Inc. PASG | BlackRock Inc. BLK | 3,491,555 6.5% | 3,491,555 (New Position) | View |
| 2021-12-10 08:52 am Sale | 13G | Passage Bio, Inc. PASG | FMR LLC | 2,667,917 4.93% | -2,610,183 (-49.45%) | View |
| 2021-10-25 5:12 pm Purchase | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 2,852,940 5.27% | 2,852,940 (New Position) | View |
| 2021-02-12 4:30 pm Sale | 13G | Passage Bio, Inc. PASG | Vivo Capital VIII LLC | 1,487,038 11% | -756,459 (-33.72%) | View |
| 2021-02-11 5:05 pm Purchase | 13G | Passage Bio, Inc. PASG | New Leaf Ventures III L.P. | 2,497,922 4.7% | 2,497,922 (New Position) | View |
| 2021-02-09 4:23 pm Purchase | 13G | Passage Bio, Inc. PASG | LAV Prescience Ltd | 2,827,328 6.2% | 2,827,328 (New Position) | View |
| 2021-02-08 10:29 am Purchase | 13G | Passage Bio, Inc. PASG | FMR LLC | 5,278,100 11.591% | 650,502 (+14.06%) | View |
| 2021-01-28 1:48 pm Unchanged | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 5,947,323 11.2% | 0 (Unchanged) | View |
| 2021-01-27 2:56 pm Purchase | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 5,021,438 9.5% | 12,219 (+0.24%) | View |
| 2020-06-10 10:13 am Purchase | 13G | Passage Bio, Inc. PASG | FMR LLC | 4,627,598 10.204% | 4,627,598 (New Position) | View |
| 2020-03-13 4:52 pm Purchase | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 9.2% | 4,026,417 (New Position) | View |